By Topic

Tumor treatment with microbubble enhanced low-intensity ultrasound and paclitaxel nanocapsules reduces drug dose required for therapeutic effect

Sign In

Cookies must be enabled to login.After enabling cookies , please use refresh or reload or ctrl+f5 on the browser for the login options.

Formats Non-Member Member
$31 $13
Learn how you can qualify for the best price for this item!
Become an IEEE Member or Subscribe to
IEEE Xplore for exclusive pricing!
close button

puzzle piece

IEEE membership options for an individual and IEEE Xplore subscriptions for an organization offer the most affordable access to essential journal articles, conference papers, standards, eBooks, and eLearning courses.

Learn more about:

IEEE membership

IEEE Xplore subscriptions

5 Author(s)
Mullin, L. ; Joint Dept. of Biomed. Eng., Univ. of North Carolina at Chapel Hill, Chapel Hill, NC, USA ; Ping Ma ; Johnson, K. ; Mumper, R.J.
more authors

Applying ultrasound in conjunction with microbubbles at the tumor site can enhance vascular permeability and motivate nanoparticle extravasation. We combine low intensity ultrasound (US) and microbubbles (MB) with drug-bearing nanocapsules (NC) to improve the therapeutic index of paclitaxel. Female mice bearing 4T1 mammary carcinoma tumors received one of five treatments: paclitaxel NC only at 2.5 mg/kg; paclitaxel NC only at 5 mg/kg; paclitaxel NC (2.5 mg/kg) prior to two minutes of therapeutic US exposure; paclitaxel NC (2.5 mg/kg) co-administered with MB prior to two minutes of therapeutic US; and control. Therapeutic US was applied using a Sonicator 740 system operated at 1 MHz, 2 W/cm2, and 10% duty cycle. At 2.5 mg/kg, mice treated with NC+MB+US had slower tumor growth compared to treatment with NC or NC+US. A statistically significant difference between NC+MB+US and both NC and NC+US groups was seen on multiple days. Data suggest treating at a dose of 2.5 mg/kg with NC+MB+US is as effective as treating with NC alone at 5 mg/kg. This finding is significant because lowering a treatment dose may reduce the risk of unwanted side effects.

Published in:

Ultrasonics Symposium (IUS), 2011 IEEE International

Date of Conference:

18-21 Oct. 2011